Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Key genes and RNA networks regulate hair growth and follicle density in Rex rabbits.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Nuclear AR levels give better insight into hormone effects in skin conditions.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

RORs may influence cashmere growth cycles.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Females are more prone to lupus and arthritis due to X chromosome factors.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

CXCR2 in skin cells promotes tumor growth.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

AHR ligands could treat inflammatory skin diseases.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.